Health Data Decisions to Deliver HEDIS® Track Keynote on Social Determinants of Health at RISE Qualipalooza Leadership Summit 2018
PHOENIX, June 22, 2018 /PRNewswire-PRWeb/ -- Health Data Decisions' CEO Michael Blumental will partner with Janine Sala, Associate Director of Clinical Quality at UnitedHealthcare, to deliver the keynote for the HEDIS® track at the 3rd Annual RISE Qualipalooza Leadership Summit on Monday, June 25th at the Arizona Biltmore in Phoenix. Their interactive presentation will discuss methods for using social determinants of health to predict and influence HEDIS® rates and quality improvement activities, including a review of data sources and practical applications.
Health Data Decisions is a platinum sponsor of RISE Qualipalooza 2018 and a conference co-chair.
Health Data Decisions is a Massachusetts-based health analytics firm founded in 2008. We offer strategic data solutions for health plans and vendors, bringing broad expertise in data management and analytics, medical economics, risk adjustment, HEDIS®, CMS 5-Star, regulatory reporting and systems strategy. Health Data Decisions brings proven expertise in assessing the effectiveness and efficiency of HEDIS® programs and helping plans understand and optimize their performance. We provide health plans with expert program management and outsourcing services to help achieve or maintain ratings, accreditations and performance incentive payment levels.
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ? Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...